Logo

Oxis in Talks to Establish Oxidative-Stress Biomarker Collaborations

Jan 17, 2005

NEW YORK, Jan. 17 (GenomeWeb News) - Oxis International said last week that it is in discussions with a number of researchers and university laboratories to research the role of oxidative-stress biomarkers in human and animal disease.


According to the company, the initial focus of the project will be on bovine spongiform encephalopathy; Creutzfeld-Jacob disease; type II diabetes; atherosclerosis; hepatitis; and neurodegenerative disorders such as Alzheimer's disease.

 

As such, Oxis said it is discussing partnerships with Claudio Soto, a researcher from the University of Texas Medical Branch; Jacek Rozga, president and CEO of Arbios Systems; Manifred Windisch, CEO of JSW Research; Noah Berkowitz, CEO of Haptoguard; and Jay Heinecke, a researcher from the University of Washington, Seattle.

 

Details about the discussions were not disclosed.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.